2025 ahead ayondo Franchise coming soon
Happy 
xMas Holidays
xMas Holidays
xMas Holidays
|
DGAP-Ad-hoc: STRATEC SE / Key word(s): Preliminary Results/Change in Forecast STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2021 AND RAISES FINANCIAL GUIDANCE Birkenfeld, October 28, 2021 Based on preliminary figures, STRATEC can report further record sales and earnings for the first nine months of 2021. According to these figures, STRATEC expects consolidated sales of € 225.4 million for the first nine months of 2021, up from € 179.1 million in the previous year. On a constant-currency basis, this corresponds to organic growth of 29.5% (nominal: +25.9%). The sales performance in the third quarter of 2021 (constant currency: +16.7%) once again exceeded the budget scenario, which was most recently adjusted upwards in July 2021. Highly dynamic developments were shown by, among others, the service parts and consumables business, as well as by molecular diagnostics and immunohematology systems. Adjusted EBIT for the first nine months of 2021 is expected to rise by 73.7% to € 48.8 million (previous year: € 28.1 million). This corresponds to an adjusted EBIT margin of 21.6% (previous year: 15.7%). The company's profitability was positively influenced in particular by benefits of scale, as well as by the sales and product mix, which exceeded recent expectations. Based on this above-budget performance in the third quarter of 2021, and given current order volumes and updated risk adjustments, the company's Board of Management has decided once again to raise the financial guidance for the 2021 financial year. As a result, STRATEC now expects to generate constant-currency sales growth of at least 16.0% in the 2021 financial year (previously: "at least 12.0%"). For its adjusted EBIT margin, the company is forecasting a figure of around 19.0% to 20.0% (previously: "around 17.5% to 18.5%"). In view of the COVID-19 pandemic, STRATEC continues to observe increased volatility in its customers' order behavior. Global supply chains also remain tense and subject to uncertainties. The above guidance therefore specifically includes risk discounts for both sales and product mixes in the fourth quarter of 2021, as well as for potential further increases in logistics costs. STRATEC will publish its Quarterly Statement with complete figures for the first nine months of 2021 as planned on November 11, 2021. Furthermore, a conference call (in English) will also be held on November 11, 2021. FURTHER INFORMATION IS AVAILABLE FROM:
28-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | STRATEC SE |
| Gewerbestr. 37 | |
| 75217 Birkenfeld | |
| Germany | |
| Phone: | +49 (0)7082 7916 0 |
| Fax: | +49 (0)7082 7916 999 |
| E-mail: | info@stratec.com |
| Internet: | www.stratec.com |
| ISIN: | DE000STRA555 |
| WKN: | STRA55 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1244430 |
| End of Announcement | DGAP News Service |
|
|
1244430 28-Oct-2021 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
